Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.
about
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic dataImpact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014Multi-atlas segmentation of biomedical images: A surveyThe Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionAtrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsThe clinical value of large neuroimaging data sets in Alzheimer's diseaseThe Alzheimer's disease neuroimaging initiative: progress report and future plansSample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.A data-driven model of biomarker changes in sporadic Alzheimer's disease.The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.Imaging endpoints for clinical trials in Alzheimer's disease.Automated methods for hippocampus segmentation: the evolution and a review of the state of the art.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2aMAP is a validated pipeline for registration and segmentation of high-resolution mouse brain data.APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.Brain MAPS: an automated, accurate and robust brain extraction technique using a template libraryAutomated template-based hippocampal segmentations from MRI: the effects of 1.5T or 3T field strength on accuracy.Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.A cognitive chameleon: lessons from a novel MAPT mutation case.The value of hippocampal and temporal horn volumes and rates of change in predicting future conversion to ADReduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustmentClassification and lateralization of temporal lobe epilepsies with and without hippocampal atrophy based on whole-brain automatic MRI segmentation.Bayesian Parameter Estimation and Segmentation in the Multi-Atlas Random Orbit Model.Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.Enrichment and stratification for predementia Alzheimer disease clinical trials.A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease.Motor features in posterior cortical atrophy and their imaging correlatesA learning-based wrapper method to correct systematic errors in automatic image segmentation: consistently improved performance in hippocampus, cortex and brain segmentation.Neural correlates of the interactive relationship between memory deficits and depressive symptoms in nondemented elderly: resting fMRI study.Characterizing Alzheimer's disease using a hypometabolic convergence index.Quantization and analysis of hippocampal morphometric changes due to dementia of Alzheimer type using metric distances based on large deformation diffeomorphic metric mapping.Measuring brain atrophy with a generalized formulation of the boundary shift integral.Using manifold learning for atlas selection in multi-atlas segmentationEvaluating Alzheimer's disease progression using rate of regional hippocampal atrophy.Altered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in Gulf War veterans.Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's diseaseSpatio-Temporal Regularization for Longitudinal Registration to Subject-Specific 3d Template.
P2860
Q24289484-1E8EA6C7-EAC2-4FF3-AF8C-87BC851280E7Q26801629-58F29BA0-985B-4EAA-9CA3-8040A8EBFCF4Q26825130-2D51EAC7-A308-4333-9384-DAC5CEA79958Q27006831-835E0042-F520-4B63-A5D7-EF0D6B19F1A0Q28488143-1766D4B4-79F6-4948-A435-FA52275B4049Q28709465-0D61B9AE-C600-417C-8820-C6AC830E1F39Q28749585-3451EA3E-D40F-4DE7-9BB3-483D3F4FD207Q30354417-13577D62-A2CA-48C2-A0E1-6CF791B437B5Q30835966-FA8D704B-C9FD-4F53-8D5C-454041F265CAQ30874688-A295D0C3-C236-4B54-A029-93843B7FDA9FQ30885979-E74E18E3-11FD-49C7-B95B-6862F0568439Q30961046-344A8775-406A-4285-90AF-ECB2B2A46116Q30971403-0A0B65C4-951B-4EA7-93F1-A6D0858904ABQ30981669-C2EFE03E-16AC-41DB-94BE-647E9EC5DA4CQ31112834-6986B32C-234B-4558-81CB-622C27B8CB07Q33690208-C7EB1C5C-37F4-46A5-A920-512A89DA06D1Q33759008-3D4C11C4-070A-468C-98F8-DCEEB166EF0DQ33783118-016EB9AF-AA36-4FC7-9374-AFA8D7173EB0Q33922735-52D1E798-9A18-46F1-855A-E3A0778711A0Q33990663-B5B80F74-25B0-458D-8FDB-AB4843EFE1BDQ34065449-6C91326B-5E18-42BF-8CCB-B4FB7AC505D5Q34120317-3C56FAF2-3183-4DFE-B1E7-E910FF29EF02Q34134551-482A1B88-CE75-43CE-A2FB-D2412ED9C8BCQ34163448-6479D653-945A-4396-B7A4-D21B4C3CA4EEQ34241612-61AE0DDD-E366-440D-81BC-478F426DB41DQ34355230-5711A02E-17F1-4CEF-9E69-143D3A2A36B7Q34364619-A428DEED-BF3D-42B6-851B-1D48D617E680Q34452239-A858B341-C701-4279-9A01-40DA15AD6689Q34473063-A0344B8A-8959-470E-AF5F-08E7B22B59DBQ34538215-BDD880FD-1DE5-4004-BDA5-BCEE565CFE23Q34629097-885CBCB2-5F3F-46C8-8C82-BD8B91657285Q34709193-D34A4FAF-9AD1-4C2D-B1FA-9E7A8B46371AQ34733606-B65B5DA5-FEAD-4573-A3F6-3A21C47A343AQ34785920-C706D6B7-B304-4F57-92BA-1EAC8E9ADA0AQ34889037-3B7FB09E-0705-40AE-94CC-AD61643BC6E1Q34924981-9B69C474-6455-4D6F-8334-589BCFDBA2C4Q34949358-CD7EB9C2-9ACD-4B13-8BB2-900CD840FB45Q35219605-77B1278C-BDAF-4D5B-A683-35EFBA3BA2D6Q35686223-705E36DB-C467-4448-A47C-016E68349BADQ35753644-D554A9A4-7435-465E-BEEC-D09AF6D6E053
P2860
Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Automated cross-sectional and ...... rment and Alzheimer's disease.
@ast
Automated cross-sectional and ...... rment and Alzheimer's disease.
@en
Automated cross-sectional and ...... rment and Alzheimer's disease.
@nl
type
label
Automated cross-sectional and ...... rment and Alzheimer's disease.
@ast
Automated cross-sectional and ...... rment and Alzheimer's disease.
@en
Automated cross-sectional and ...... rment and Alzheimer's disease.
@nl
prefLabel
Automated cross-sectional and ...... rment and Alzheimer's disease.
@ast
Automated cross-sectional and ...... rment and Alzheimer's disease.
@en
Automated cross-sectional and ...... rment and Alzheimer's disease.
@nl
P2093
P2860
P50
P1433
P1476
Automated cross-sectional and ...... rment and Alzheimer's disease.
@en
P2093
Kate Macdonald
Kelvin K Leung
Matthew J Clarkson
Norbert Schuff
P2860
P304
P356
10.1016/J.NEUROIMAGE.2010.03.018
P407
P50
P577
2010-03-15T00:00:00Z